Toxicity of treatment regimens for drugresistant tuberculosis.
Background. The main factors reducing treatment effectiveness in patients with pulmonary tuberculosis are as follows: the growing drug resistance of mycobacteria, which necessitates the strengthening of chemotherapy regimens, the use of new antimicrobial drugs, as well as poor tolerability of treatm...
Saved in:
Main Authors: | G. N. Mozhokina, Yu. R. Zyuzya, L. Yu. Petrova, A. G. Samoilova, I. A. Vasilyeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Publishing House OKI"
2022-03-01
|
Series: | Антибиотики и Химиотерапия |
Subjects: | |
Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/874 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis
by: А. V. Kukurika
Published: (2022-10-01) -
Beyond treatment and cure: Burden of adverse drug reactions in a case of multidrug-resistant tuberculosis
by: Sagarika N. Suresh, et al.
Published: (2025-01-01) -
Safety and Efficacy of Bedaquiline in Drug Resistant Tuberculosis: A Hospital-based Prospective Observational Study
by: Saima Ejaz, et al.
Published: (2025-06-01) -
Adverse Drug Reactions in Multidrug-resistant Tuberculosis Patients on Longer Bedaquiline-based Regimen at a Tertiary Care Center in Mumbai
by: Abhishek Saini, et al.
Published: (2025-07-01) -
Algorithm for assigning different 6-month short-term chemotherapy regimens in patients with drug-resistant tuberculosis: how to make the right choice for the clinician
by: Yu.I. Feshchenko, et al.
Published: (2025-06-01)